Rigel Pharmaceuticals Signs Global Licensing Deal for VEPPANU™ Breast Cancer Treatment
Rigel Pharmaceuticals has entered an exclusive global licensing agreement with Arvinas and…
Pfizer Reaches Three Settlement Agreements for VYNDAMAX
Pfizer has reached settlement agreements with multiple generic manufacturers over VYNDAMAX (tafamidis),…
Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma
Pfizer Inc. (NYSE: PFE) today announced it has entered into an exclusive…
Pfizer Marks a Major Milestone in the Fight Against Antimicrobial Resistance in the UAE
Pfizer announced the introduction of a novel treatment in the United Arab…
Pfizer Completes Licensing Agreement with 3SBio
Exclusive license to promising investigational cancer immunotherapy complements and strengthens Pfizer’s innovative…
Phase 3 EMBARK Study Confirms XTANDI Plus Leuprolide Improves Overall Survival in Non-Metastatic Prostate Cancer
Pfizer Inc. and Astellas Pharma Inc. announced positive topline results from the…
Two Days to Go, London Biotechnology Show 2025 Gears Up to Spotlight Industry Pioneers, DisruptiveTech, Emerging Innovators
In just two days, the second edition of the London Biotechnology Show…
Pfizer Appoints Elif Aral as Regional President for MERA Region
Dubai, UAE— Pfizer recently announced the appointment of Elif Aral as Regional…
Pfizer Launches Digital Hub for Simplified Healthcare Access
New York- August 2024- Pfizer introduced PfizerForAll, a user-friendly digital platform designed…
FDA Approves Updated mRNA COVID-19 Vaccines for Current Variants
Recently, the U.S. Food and Drug Administration approved and granted emergency use…